Sign inJoin waitlistJoin the waitlist

Nisha Joseph

Physician · Emory University School of Medicine

Credentials: · · · · ·

History

Emory University School of Medicine
Present

Hematology and Medical Oncology
Emory University School of Medicine
2015–2018
Internal Medicine
Emory University School of Medicine
2012–2015
Ohio State University College of Medicine
2008–2012

Research

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
Journal of Clinical Oncology · 2020 · First of 10 authors · 213 citations
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
Blood Cancer Journal · 2019 · 149 citations
Daratumumab in multiple myeloma
Review · Cancer · 2019 · 129 citations

Sagar Lonial
38 papers
Ajay Nooka
34 papers
Jonathan Kaufman
32 papers
Craig Hofmeister
27 papers
Madhav Dhodapkar
27 papers
Vikas Gupta
20 papers
LH
Leonard Heffner
10 papers
Kavita Dhodapkar
9 papers
David Jaye
5 papers
Amelia Langston
3 papers
Andrew Neish
3 papers
Danielle Roberts
3 papers

Clinical trials

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Principal investigator · Recruiting · Phase 2
Emory University
2021–2029
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2020–2023
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Site PI · Recruiting · Phase 1
Kelonia Therapeutics, Inc.
2025–2042
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2019–2029